All’interno dell’evento Ever 2015 di Nizza, il 9 Ottobre dalle 12.30 alle 13.30, si terrà il convegno organizzato dall'azienda farmaceutica Santhera “Breakthrough in mitochondrial medicine: changing the patient journey in LHON”.
Moderatori:
Dr P. Barboni: Consultant Neuro-Ophthalmologist, San Raffaele Scientific Institute (Milan) and D’Azeglio Ophthalmology Institute (Bologna);
Dr.ssa P. Morandi Treu: President Vivivejo No-Profit Patient Association
Titoli delle Relazioni e Invited Speakers:
- Optic neurodegeneration – the time to act is now (Nuri Gueven, Associated Professor and Senior Research Fellow Un. of Tasmania, Hobart - 12:35-12:50)
- Reaching key milestones in LHON – the idebenone clinical development program (Günther Metz, Senior VP Business Development, Santhera Pharm., Liestal - 12:50-13:00)
- Changing the patient journey in LHON: the evidence (Thomas Klopstock, Professor of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University München – 13:00-13:20)
- Q&A with panel” (Chair(s) – 13:20-13:30)
Seguici sui Social